Cancer Types
& Treatment
Directions
& Facilities
Our
Team
Research
& Clinical Trials
TakeCharge!
Home
GO
Clinical Trials
Choosing to participate in a Clinical Trial is a very personal decision – and something you and your entire Moffitt care team can decide together.
Find a Researcher
Research Disciplines
Programs
Departments
Centers of Excellence
Working Groups
Clinical Trials
Clinical Trial Definitions
Informed Consent
Patient Protection
Ten Things to Know
Questions to Ask Your Doctor
Hematology Clinical Trials
Clinical Trials Video
Consortia and Co-Op Groups
Clinical Trials Administration
Research Cores & Technology
Current Research
Partnerships & Studies
ICARE
Ponce School of Medicine
Physical Science Oncology Center
Tampa Bay Community Center Network
M2Gen
Path to Commercialization
Business of Biotech
2013 Event Info
Registration
Department of Oncologic Sciences
Education & Training
Cancer Control Journal
Funding Opportunities
Events in Research
Clinical Trials
Where You Are:
Home
>
Research & Clinical Trials
>
Clinical Trials
Search Clinical Trials
BY CANCER
OR
BY DRUG
OR
STUDY TITLE
(KEYWORD)
(Optional) Show only results for open trials at:
Moffitt Only
Affiliates Only
Select Cancer Type
Anus
Leukemia, not otherwise specified
Other Hematopoietic
Any Site
Leukemia, other
Other Male Genital
Bladder
Lip, Oral Cavity and Pharynx
Other Respiratory and Intrathoracic Organs
Bones and Joints
Liver
Other Skin
Brain and Nervous System
Lung
Other Urinary
Breast - Female
Lymphoid Leukemia
Ovary
Breast - Male
Melanoma, skin
Pancreas
Cervix Uteri
Multiple Myeloma
Prostate
Colon
Mycosis Fungoides
Rectum
Corpus Uteri
Myeloid and Monocytic Leukemia
Small Intestine
Esophagus
Non-Hodgkin's Lymphoma
Soft Tissue
Eye and Orbit
Other Digestive Organ
Stomach
Hodgkin's Lymphoma
Other Endocrine System
Thyroid
Kidney
Other Female Genital
Unknown Sites
Larynx
Select Drug Type
18F-fluoromisonidazole
Eltrombopag olamine
PCI-32765
1-Methyl-D-tryptophan
Erbitux
PCV13
5-fluorouracil
Eribulin Mesylate
PD 0332991
6-mercaptopurine
Erlotinib
Peg-asparaginase
ACE-011
everolimus
Pemetrexed
Ad.p53 DC
Faslodex
PF-04449913
Adcetris
Fidaxomicin
Placebo
Adriamycin
FK228
Plerixafor
AGS-003
FK506
PLX-4032
Aldesleukin
Flavopiridol
Poly IC-LC
Alimta
fludarabine
Polyphenon E
Alisertib
Fluticasone
Pomalidomide
Alkeran
FOLFIRI
Pralatrexate
Alpharadin
FOLFOX
prednisone
ALT-801
fulvestrant
Procarbazine
AMD3100
Gardasil
Proleukin
AMG 386
G-CSF
PS-341
AMG 655
gemcitabine
Purified Isofavones/placebo
AP23573
Gemtuzumab Ozogamicin
PV-10
ARQ 197
Gemzar
PX-866
ARRY-614
GM.CD40L
PXD101
Arsenic Trioxide
GM.CD40L.CCL21
RAD001
AS15 ASCI
GM-CSF
Radium-223 chloride
ATG
goserelin acetate
Rapamune
ATRA
gp 100:209-217(210) Peptide
Rapamycin
Autologous Dendritic Cells
gp 100:280-288 (288V) Peptide
recMAGE-A3 + AS15 ASCI
Avastin
GSK2118436
recNY-ESO-1
axitinib
GSK2241658A
Regorafenib
AZD2171
Gw572016
Revlimid
Azithromycin
Ibritumomab tiuxetan
RGI-2001
BAY 43-9006
Idarubicin
Ridaforolimus
BAY 73-4506
IL-2
Rituxan
BAY 80-6946
Indoximod
rituximab
BCG
In-epratuzumab
RO5185426
Belinostat
interferon alpha 2b
Romidepsin
Bevacizumab
Interleukin-2
Ruxolitinib
Bexarotene
IPI-504
SAHA
BEZ235
Ipilimumab
sargramostatin
BKM120
irinotecan
SGN-35
BMS-936558
Jakafi
SGN-CD19A
BMS-936564
Jevtana
Sirolimus
BMS-982470
KB004
SOM230
BMS-986015
KPT-330
Sorafenib
Bortezomib
KW-0761
Sotatercept
Brentuximab vedotin
Lapatinib
Standard of Care
busulfan
LCL 161
suberoylanilide hydroxamic acid
BYM338
LDE225
Sunitinib Malate
Cabazitaxel
lenalidomide
Sylatron
Cabozantinib
Leukine
Tacrolimus
Camptosar
Leuprolide
Tarceva
capecitabine
LGX818
Taxol
carboplatin
Liposomal Cisplatin
Taxotere
CC-115
MART-1:26-35(27L) Peptide
Temodal
CC-223
MDX-1106
Temozolomide
CC-4047
MEDI4736
Temsirolimus
CC-5013
MEGF0444A
TH-302
CCI-779
MEK162
TIL
Cediranib
Melphalan
Tivantinib
Cetuximab
Metformin
TKI258
CH5424802
methotrexate
Topotecan
cisplatin
Methylprednisolone
Trabectedin
CPT-11
mitoxantrone
Trisenox
CPX-351
MK-1775
U3-1287
CRS-207
MK-3475
Unconjugated Epratuzumab
Custirsen sodium
MK-8242
US-ATG-F
cyclophosphamide
MK-8669
Ustekinumab/placebo
Cyclosporine
MLN0264
V503
Cytarabine
Montanide ISA 51 VG
Valrubicin
Cytosine Arabinoside
montelukast
Valstar
cytoxan
MORAb-004
Velban
dabrafenib
Mozobil
Velcade
Dacarbazine
MPDL3280A
Veliparib
Dasatinib
Mylotarg
Veltuzamab
Daunomycin
NeuVax
Vemurafenib
daunorubicin
Nilotinib
Vinblastine
Decavac
Nivolumab
Vincristine
decitabine
Not Applicable
Vorinostat
Dexamethasone
Novantrone
Vosaroxin
DN24-02
NY-ESO-1:157-165(165V) Peptide
Xeloda
docetaxel
Ofatumumab
XL888
Dovitinib
OSI-906
Y-Epratuzumab Tetraxetan
Doxil
Other
Yervoy
doxorubicin
paclitaxel
Yondelis
doxorubicin liposome
Paraplatin
Zelboraf
DTIC
pasireotide LAR
Zevados
E7080
Patritumab
Zoladex
Eligard
Pazopanib
Zolinza